Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Barnes & Noble Education Announces Surge in New Campus Store Partnerships
-
ElevateBio Appoints Ger Brophy, Ph.D., as Interim Chief Executive Officer and Member of the Board of Directors
-
CSW Industrials Announces Date for Fiscal Fourth Quarter and Full Year 2025 Earnings Release Conference Call
-
Ascot Provides Update on Board of Directors
-
IBN Announces CryptoNewsAudio Production Featuring Andrew Gordon, Managing Attorney of Gordon Law Group
-
Oragenics, Inc. to Host Management Update Webinar on May 20, 2025 to Discuss Concussion Treatment Landscape, ONP-002 Clinical Program, and Strategic Vision
-
Skillful Craftsman Education Announces Key Hires for New Business Expansion Initiatives
-
NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor
-
Freight Technologies to Purchase Additional $1 Million of Official Trump Tokens
-
LM Funding America Announces April 2025 Production and Operational Update
-
CEO T.J. Rodgers Letter to SPWR Shareholders
-
Brag House, in partnership with Florida Gator Athletics and Learfield’s Florida Gators Sports Properties, Launches the Inaugural “Brag Gators Gauntlet” Series Baseball Edition at the University
-
MDWerks’ Two Trees Beverage Subsidiary Launches Uplifting Spirits, a New Product Line Focused on Supporting Community and Charitable Causes
-
Rush Street Interactive Announces Initiative Supporting Increased Gaming Literacy For Teens
-
Biodexa Receives Orphan Drug Designation in Europe for eRapa in FAP
-
Duke Robotics Announces Commencement of 2025 Insulator Cleaning Activity with Israel Electric Corporation
-
TMC Announces $37 Million Strategic Investment to Advance Deep-Sea Mineral Development
-
Alert: Grabar Law Office is Investigating Claims on Behalf Long-Term Shareholders of Applovin Corporation (NASDAQ: APP); Maison Solutions, Inc. (NASDAQ: MSS); Treace Medical Concepts, Inc. (NASDAQ: TM
-
Plethora Businesses Represents Ferralloy, Inc. in Strategic Acquisition by EQI
-
Form 8.5 (EPT/RI) - De La Rue plc
-
NeurAxis Reports Strong First Quarter 2025 Financial Results Driven by a 39% Growth in Revenues
-
The Six Five Summit: AI Unleashed 2025 Explores the Future of Artificial Intelligence
-
Collegium Announces $25 Million Accelerated Share Repurchase Program
-
Registration for 2025 World Astatine Community Meeting Now Open
-
ABLi Therapeutics Launches with a Focus on Developing Treatments for Neurodegenerative Diseases that Arise from Activation of c-Abl Kinases
-
CHAR Tech Closes C$2M Private Placement with The BMI Group
-
Pieridae Energy Changes Name to Cavvy Energy
-
Bioliberty Launches Lifehub Clinic to Transform Therapy through Soft Robotics and Gamified Exercises
-
Lincoln Educational Services Reports First Quarter Financial Results: Double Digit Growth in Revenue and Student Starts, Increased Outlook for Full Year 2025
-
APEX Capital Group Launches $10M Halal Real Estate Income Fund
-
Keros Therapeutics Announces Participation at Bank of America 2025 Global Healthcare Conference
-
Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation
-
Enphase Energy Expands in Europe with the IQ Balcony Solar System in Belgium
-
Windtree Therapeutics Announces Presentation of Preclinical Data on Istaroxime and a Selective SERCA2a Activator at the European Society of Cardiology Heart Failure Conference May 17, 2025
-
TX Rail Products, Inc. Reports Financial Results for Second Quarter of Fiscal 2025
-
IN8bio Presents Data at ISCT 2025 Demonstrating Proprietary γδ T cell Manufacturing Generates Consistent and Robust Clinical Products
-
Conifex Announces First Quarter 2025 Results
-
CervoMed Reports First Quarter 2025 Financial Results and Provides Corporate Updates
-
ArriVent BioPharma Reports First Quarter 2025 Financial Results
-
MBX Biosciences Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
-
CPS Technologies to Participate in Sidoti Microcap Virtual Conference
-
ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31, 2025
-
Vaxart Addresses Frequently Asked Questions on Reverse Stock Split Proposal in Definitive Proxy Statement
-
Opus Genetics Announces Presentations on Inherited Retinal Disease Programs at Medical Conferences in May
-
Galectin Therapeutics Presented NAVIGATE Trial Results at the European Association for the Study of the Liver (EASL) 2025 Congress
-
Gabelli Funds to Host 17th Annual Media & Entertainment Symposium Thursday, June 5, 2025
-
Foresight Diagnostics to Participate in the Jefferies Global Healthcare Conference
-
Tracy Robinson to address the 18th Annual Wolfe Research Global Transportation & Industrials Conference on May 20
-
Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee (DSMC)
-
Glass House Brands to Hold Investor Sesh IV on Friday, June 20th
